Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells
Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-...
Gespeichert in:
Veröffentlicht in: | International journal of cancer 2025-02, Vol.156 (3), p.638 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 3 |
container_start_page | 638 |
container_title | International journal of cancer |
container_volume | 156 |
creator | Wang, Ruonan Hu, Mengwen Lozzi, Isis Jin, Cao Zhong Jing Ma, Dou Splith, Katrin Mengwasser, Jörg Wolf, Vincent Feldbrügge, Linda Tang, Peter Timmermann, Lea Hillebrandt, Karl Herbert Kirchner, Marieluise Mertins, Philipp Hilfenhaus, Georg Neumann, Christopher Claudius Maximilian Kammertoens, Thomas Pratschke, Johann Malinka, Thomas Sauer, Igor Maximillian Noessner, Elfriede Guo, Zong Sheng Felsenstein, Matthäus |
description | Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-selective (vvDD) and cytokine-armed Western-reserve vaccinia viruses (vvDD-IL2 and vvDD-IL15) and infected carcinoma cell lines as well as patient-derived primary PDAC cells. In co-culture experiments, we investigated the cytotoxic response and the activation of human natural killer (NK). Infection and virus replication were assessed by measuring virus encoded YFP. We then analyzed intracellular signaling processes and oncolysis via in-depth proteomic analysis, immunoblotting and TUNEL assay. Following the co-culture of mock or virus infected carcinoma cell lines with allogenic PBMCs or NK cell lines, CD56
NK cells were analyzed with respect to their activation, cytotoxicity and effector function. Both, dose- and time-dependent release of danger signals following infection were measured. Viruses effectively entered PDAC cells, emitted YFP signals and resulted in concomitant oncolysis. The proteome showed reprogramming of normally active core signaling pathways in PDAC (e.g., MAPK-ERK signaling). Danger-associated molecular patterns were released upon infection and stimulated co-cultured NK cells for enhanced effector cytotoxicity. NK cell subtyping revealed enhanced numbers and activation of a rare CD56
CD16
population. Tumor cell killing was primarily triggered via Fas ligands rather than granule release, resulting in marked apoptosis. Overall, the cytokine-armed vaccinia viruses induced NK cell activation and enhanced cytotoxicity toward human PDAC cells in vitro. We could show that cytokine-armed virus targets the carcinoma cells and thus has great potential to modulate the TIME in PDAC. |
format | Article |
fullrecord | <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_39400317</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>39400317</sourcerecordid><originalsourceid>FETCH-pubmed_primary_394003173</originalsourceid><addsrcrecordid>eNqFj11Ow0AMhFdIiJafKyBfINIuaaj6HEAcgPfKOFthuj-R1wnkONyURYVnnmakmfksn5m1s7ttY-9ctzKXpbxb61xnNxdm1e421rZuuzZf_aL5yMk3KNEPMCMRJ0aYWaYCo-SY1RegWtP8ycS6gOYPlAFGTCQelQkIpc5yRCAfQqlrBCTluaY5QT7A2xQxASf1P3cYZYH-obuHgWM17mQS6iQY4MgheDmxrs35AUPxN796ZW6fHl_652acXitpPwrHStv__dT-W_gGZWFalw</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Wang, Ruonan ; Hu, Mengwen ; Lozzi, Isis ; Jin, Cao Zhong Jing ; Ma, Dou ; Splith, Katrin ; Mengwasser, Jörg ; Wolf, Vincent ; Feldbrügge, Linda ; Tang, Peter ; Timmermann, Lea ; Hillebrandt, Karl Herbert ; Kirchner, Marieluise ; Mertins, Philipp ; Hilfenhaus, Georg ; Neumann, Christopher Claudius Maximilian ; Kammertoens, Thomas ; Pratschke, Johann ; Malinka, Thomas ; Sauer, Igor Maximillian ; Noessner, Elfriede ; Guo, Zong Sheng ; Felsenstein, Matthäus</creator><creatorcontrib>Wang, Ruonan ; Hu, Mengwen ; Lozzi, Isis ; Jin, Cao Zhong Jing ; Ma, Dou ; Splith, Katrin ; Mengwasser, Jörg ; Wolf, Vincent ; Feldbrügge, Linda ; Tang, Peter ; Timmermann, Lea ; Hillebrandt, Karl Herbert ; Kirchner, Marieluise ; Mertins, Philipp ; Hilfenhaus, Georg ; Neumann, Christopher Claudius Maximilian ; Kammertoens, Thomas ; Pratschke, Johann ; Malinka, Thomas ; Sauer, Igor Maximillian ; Noessner, Elfriede ; Guo, Zong Sheng ; Felsenstein, Matthäus</creatorcontrib><description>Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-selective (vvDD) and cytokine-armed Western-reserve vaccinia viruses (vvDD-IL2 and vvDD-IL15) and infected carcinoma cell lines as well as patient-derived primary PDAC cells. In co-culture experiments, we investigated the cytotoxic response and the activation of human natural killer (NK). Infection and virus replication were assessed by measuring virus encoded YFP. We then analyzed intracellular signaling processes and oncolysis via in-depth proteomic analysis, immunoblotting and TUNEL assay. Following the co-culture of mock or virus infected carcinoma cell lines with allogenic PBMCs or NK cell lines, CD56
NK cells were analyzed with respect to their activation, cytotoxicity and effector function. Both, dose- and time-dependent release of danger signals following infection were measured. Viruses effectively entered PDAC cells, emitted YFP signals and resulted in concomitant oncolysis. The proteome showed reprogramming of normally active core signaling pathways in PDAC (e.g., MAPK-ERK signaling). Danger-associated molecular patterns were released upon infection and stimulated co-cultured NK cells for enhanced effector cytotoxicity. NK cell subtyping revealed enhanced numbers and activation of a rare CD56
CD16
population. Tumor cell killing was primarily triggered via Fas ligands rather than granule release, resulting in marked apoptosis. Overall, the cytokine-armed vaccinia viruses induced NK cell activation and enhanced cytotoxicity toward human PDAC cells in vitro. We could show that cytokine-armed virus targets the carcinoma cells and thus has great potential to modulate the TIME in PDAC.</description><identifier>EISSN: 1097-0215</identifier><identifier>PMID: 39400317</identifier><language>eng</language><publisher>United States</publisher><subject>Carcinoma, Pancreatic Ductal - immunology ; Carcinoma, Pancreatic Ductal - metabolism ; Carcinoma, Pancreatic Ductal - pathology ; Carcinoma, Pancreatic Ductal - virology ; CD56 Antigen - metabolism ; Cell Line, Tumor ; Coculture Techniques ; Cytotoxicity, Immunologic ; Humans ; Interleukin-15 - metabolism ; Interleukin-2 - metabolism ; Killer Cells, Natural - immunology ; Killer Cells, Natural - metabolism ; Oncolytic Virotherapy - methods ; Oncolytic Viruses - immunology ; Pancreatic Neoplasms - immunology ; Pancreatic Neoplasms - metabolism ; Pancreatic Neoplasms - pathology ; Pancreatic Neoplasms - virology ; Tumor Microenvironment - immunology ; Vaccinia virus - immunology</subject><ispartof>International journal of cancer, 2025-02, Vol.156 (3), p.638</ispartof><rights>2024 The Author(s). International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-3146-8717</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39400317$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Ruonan</creatorcontrib><creatorcontrib>Hu, Mengwen</creatorcontrib><creatorcontrib>Lozzi, Isis</creatorcontrib><creatorcontrib>Jin, Cao Zhong Jing</creatorcontrib><creatorcontrib>Ma, Dou</creatorcontrib><creatorcontrib>Splith, Katrin</creatorcontrib><creatorcontrib>Mengwasser, Jörg</creatorcontrib><creatorcontrib>Wolf, Vincent</creatorcontrib><creatorcontrib>Feldbrügge, Linda</creatorcontrib><creatorcontrib>Tang, Peter</creatorcontrib><creatorcontrib>Timmermann, Lea</creatorcontrib><creatorcontrib>Hillebrandt, Karl Herbert</creatorcontrib><creatorcontrib>Kirchner, Marieluise</creatorcontrib><creatorcontrib>Mertins, Philipp</creatorcontrib><creatorcontrib>Hilfenhaus, Georg</creatorcontrib><creatorcontrib>Neumann, Christopher Claudius Maximilian</creatorcontrib><creatorcontrib>Kammertoens, Thomas</creatorcontrib><creatorcontrib>Pratschke, Johann</creatorcontrib><creatorcontrib>Malinka, Thomas</creatorcontrib><creatorcontrib>Sauer, Igor Maximillian</creatorcontrib><creatorcontrib>Noessner, Elfriede</creatorcontrib><creatorcontrib>Guo, Zong Sheng</creatorcontrib><creatorcontrib>Felsenstein, Matthäus</creatorcontrib><title>Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-selective (vvDD) and cytokine-armed Western-reserve vaccinia viruses (vvDD-IL2 and vvDD-IL15) and infected carcinoma cell lines as well as patient-derived primary PDAC cells. In co-culture experiments, we investigated the cytotoxic response and the activation of human natural killer (NK). Infection and virus replication were assessed by measuring virus encoded YFP. We then analyzed intracellular signaling processes and oncolysis via in-depth proteomic analysis, immunoblotting and TUNEL assay. Following the co-culture of mock or virus infected carcinoma cell lines with allogenic PBMCs or NK cell lines, CD56
NK cells were analyzed with respect to their activation, cytotoxicity and effector function. Both, dose- and time-dependent release of danger signals following infection were measured. Viruses effectively entered PDAC cells, emitted YFP signals and resulted in concomitant oncolysis. The proteome showed reprogramming of normally active core signaling pathways in PDAC (e.g., MAPK-ERK signaling). Danger-associated molecular patterns were released upon infection and stimulated co-cultured NK cells for enhanced effector cytotoxicity. NK cell subtyping revealed enhanced numbers and activation of a rare CD56
CD16
population. Tumor cell killing was primarily triggered via Fas ligands rather than granule release, resulting in marked apoptosis. Overall, the cytokine-armed vaccinia viruses induced NK cell activation and enhanced cytotoxicity toward human PDAC cells in vitro. We could show that cytokine-armed virus targets the carcinoma cells and thus has great potential to modulate the TIME in PDAC.</description><subject>Carcinoma, Pancreatic Ductal - immunology</subject><subject>Carcinoma, Pancreatic Ductal - metabolism</subject><subject>Carcinoma, Pancreatic Ductal - pathology</subject><subject>Carcinoma, Pancreatic Ductal - virology</subject><subject>CD56 Antigen - metabolism</subject><subject>Cell Line, Tumor</subject><subject>Coculture Techniques</subject><subject>Cytotoxicity, Immunologic</subject><subject>Humans</subject><subject>Interleukin-15 - metabolism</subject><subject>Interleukin-2 - metabolism</subject><subject>Killer Cells, Natural - immunology</subject><subject>Killer Cells, Natural - metabolism</subject><subject>Oncolytic Virotherapy - methods</subject><subject>Oncolytic Viruses - immunology</subject><subject>Pancreatic Neoplasms - immunology</subject><subject>Pancreatic Neoplasms - metabolism</subject><subject>Pancreatic Neoplasms - pathology</subject><subject>Pancreatic Neoplasms - virology</subject><subject>Tumor Microenvironment - immunology</subject><subject>Vaccinia virus - immunology</subject><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFj11Ow0AMhFdIiJafKyBfINIuaaj6HEAcgPfKOFthuj-R1wnkONyURYVnnmakmfksn5m1s7ttY-9ctzKXpbxb61xnNxdm1e421rZuuzZf_aL5yMk3KNEPMCMRJ0aYWaYCo-SY1RegWtP8ycS6gOYPlAFGTCQelQkIpc5yRCAfQqlrBCTluaY5QT7A2xQxASf1P3cYZYH-obuHgWM17mQS6iQY4MgheDmxrs35AUPxN796ZW6fHl_652acXitpPwrHStv__dT-W_gGZWFalw</recordid><startdate>20250201</startdate><enddate>20250201</enddate><creator>Wang, Ruonan</creator><creator>Hu, Mengwen</creator><creator>Lozzi, Isis</creator><creator>Jin, Cao Zhong Jing</creator><creator>Ma, Dou</creator><creator>Splith, Katrin</creator><creator>Mengwasser, Jörg</creator><creator>Wolf, Vincent</creator><creator>Feldbrügge, Linda</creator><creator>Tang, Peter</creator><creator>Timmermann, Lea</creator><creator>Hillebrandt, Karl Herbert</creator><creator>Kirchner, Marieluise</creator><creator>Mertins, Philipp</creator><creator>Hilfenhaus, Georg</creator><creator>Neumann, Christopher Claudius Maximilian</creator><creator>Kammertoens, Thomas</creator><creator>Pratschke, Johann</creator><creator>Malinka, Thomas</creator><creator>Sauer, Igor Maximillian</creator><creator>Noessner, Elfriede</creator><creator>Guo, Zong Sheng</creator><creator>Felsenstein, Matthäus</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><orcidid>https://orcid.org/0000-0003-3146-8717</orcidid></search><sort><creationdate>20250201</creationdate><title>Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells</title><author>Wang, Ruonan ; Hu, Mengwen ; Lozzi, Isis ; Jin, Cao Zhong Jing ; Ma, Dou ; Splith, Katrin ; Mengwasser, Jörg ; Wolf, Vincent ; Feldbrügge, Linda ; Tang, Peter ; Timmermann, Lea ; Hillebrandt, Karl Herbert ; Kirchner, Marieluise ; Mertins, Philipp ; Hilfenhaus, Georg ; Neumann, Christopher Claudius Maximilian ; Kammertoens, Thomas ; Pratschke, Johann ; Malinka, Thomas ; Sauer, Igor Maximillian ; Noessner, Elfriede ; Guo, Zong Sheng ; Felsenstein, Matthäus</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-pubmed_primary_394003173</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Carcinoma, Pancreatic Ductal - immunology</topic><topic>Carcinoma, Pancreatic Ductal - metabolism</topic><topic>Carcinoma, Pancreatic Ductal - pathology</topic><topic>Carcinoma, Pancreatic Ductal - virology</topic><topic>CD56 Antigen - metabolism</topic><topic>Cell Line, Tumor</topic><topic>Coculture Techniques</topic><topic>Cytotoxicity, Immunologic</topic><topic>Humans</topic><topic>Interleukin-15 - metabolism</topic><topic>Interleukin-2 - metabolism</topic><topic>Killer Cells, Natural - immunology</topic><topic>Killer Cells, Natural - metabolism</topic><topic>Oncolytic Virotherapy - methods</topic><topic>Oncolytic Viruses - immunology</topic><topic>Pancreatic Neoplasms - immunology</topic><topic>Pancreatic Neoplasms - metabolism</topic><topic>Pancreatic Neoplasms - pathology</topic><topic>Pancreatic Neoplasms - virology</topic><topic>Tumor Microenvironment - immunology</topic><topic>Vaccinia virus - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Ruonan</creatorcontrib><creatorcontrib>Hu, Mengwen</creatorcontrib><creatorcontrib>Lozzi, Isis</creatorcontrib><creatorcontrib>Jin, Cao Zhong Jing</creatorcontrib><creatorcontrib>Ma, Dou</creatorcontrib><creatorcontrib>Splith, Katrin</creatorcontrib><creatorcontrib>Mengwasser, Jörg</creatorcontrib><creatorcontrib>Wolf, Vincent</creatorcontrib><creatorcontrib>Feldbrügge, Linda</creatorcontrib><creatorcontrib>Tang, Peter</creatorcontrib><creatorcontrib>Timmermann, Lea</creatorcontrib><creatorcontrib>Hillebrandt, Karl Herbert</creatorcontrib><creatorcontrib>Kirchner, Marieluise</creatorcontrib><creatorcontrib>Mertins, Philipp</creatorcontrib><creatorcontrib>Hilfenhaus, Georg</creatorcontrib><creatorcontrib>Neumann, Christopher Claudius Maximilian</creatorcontrib><creatorcontrib>Kammertoens, Thomas</creatorcontrib><creatorcontrib>Pratschke, Johann</creatorcontrib><creatorcontrib>Malinka, Thomas</creatorcontrib><creatorcontrib>Sauer, Igor Maximillian</creatorcontrib><creatorcontrib>Noessner, Elfriede</creatorcontrib><creatorcontrib>Guo, Zong Sheng</creatorcontrib><creatorcontrib>Felsenstein, Matthäus</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Ruonan</au><au>Hu, Mengwen</au><au>Lozzi, Isis</au><au>Jin, Cao Zhong Jing</au><au>Ma, Dou</au><au>Splith, Katrin</au><au>Mengwasser, Jörg</au><au>Wolf, Vincent</au><au>Feldbrügge, Linda</au><au>Tang, Peter</au><au>Timmermann, Lea</au><au>Hillebrandt, Karl Herbert</au><au>Kirchner, Marieluise</au><au>Mertins, Philipp</au><au>Hilfenhaus, Georg</au><au>Neumann, Christopher Claudius Maximilian</au><au>Kammertoens, Thomas</au><au>Pratschke, Johann</au><au>Malinka, Thomas</au><au>Sauer, Igor Maximillian</au><au>Noessner, Elfriede</au><au>Guo, Zong Sheng</au><au>Felsenstein, Matthäus</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2025-02-01</date><risdate>2025</risdate><volume>156</volume><issue>3</issue><spage>638</spage><pages>638-</pages><eissn>1097-0215</eissn><abstract>Pancreatic ductal adenocarcinoma (PDAC) remains a particularly aggressive disease with few effective treatments. The PDAC tumor immune microenvironment (TIME) is known to be immune suppressive. Oncolytic viruses can increase tumor immunogenicity via immunogenic cell death (ICD). We focused on tumor-selective (vvDD) and cytokine-armed Western-reserve vaccinia viruses (vvDD-IL2 and vvDD-IL15) and infected carcinoma cell lines as well as patient-derived primary PDAC cells. In co-culture experiments, we investigated the cytotoxic response and the activation of human natural killer (NK). Infection and virus replication were assessed by measuring virus encoded YFP. We then analyzed intracellular signaling processes and oncolysis via in-depth proteomic analysis, immunoblotting and TUNEL assay. Following the co-culture of mock or virus infected carcinoma cell lines with allogenic PBMCs or NK cell lines, CD56
NK cells were analyzed with respect to their activation, cytotoxicity and effector function. Both, dose- and time-dependent release of danger signals following infection were measured. Viruses effectively entered PDAC cells, emitted YFP signals and resulted in concomitant oncolysis. The proteome showed reprogramming of normally active core signaling pathways in PDAC (e.g., MAPK-ERK signaling). Danger-associated molecular patterns were released upon infection and stimulated co-cultured NK cells for enhanced effector cytotoxicity. NK cell subtyping revealed enhanced numbers and activation of a rare CD56
CD16
population. Tumor cell killing was primarily triggered via Fas ligands rather than granule release, resulting in marked apoptosis. Overall, the cytokine-armed vaccinia viruses induced NK cell activation and enhanced cytotoxicity toward human PDAC cells in vitro. We could show that cytokine-armed virus targets the carcinoma cells and thus has great potential to modulate the TIME in PDAC.</abstract><cop>United States</cop><pmid>39400317</pmid><orcidid>https://orcid.org/0000-0003-3146-8717</orcidid></addata></record> |
fulltext | fulltext |
identifier | EISSN: 1097-0215 |
ispartof | International journal of cancer, 2025-02, Vol.156 (3), p.638 |
issn | 1097-0215 |
language | eng |
recordid | cdi_pubmed_primary_39400317 |
source | MEDLINE; Access via Wiley Online Library |
subjects | Carcinoma, Pancreatic Ductal - immunology Carcinoma, Pancreatic Ductal - metabolism Carcinoma, Pancreatic Ductal - pathology Carcinoma, Pancreatic Ductal - virology CD56 Antigen - metabolism Cell Line, Tumor Coculture Techniques Cytotoxicity, Immunologic Humans Interleukin-15 - metabolism Interleukin-2 - metabolism Killer Cells, Natural - immunology Killer Cells, Natural - metabolism Oncolytic Virotherapy - methods Oncolytic Viruses - immunology Pancreatic Neoplasms - immunology Pancreatic Neoplasms - metabolism Pancreatic Neoplasms - pathology Pancreatic Neoplasms - virology Tumor Microenvironment - immunology Vaccinia virus - immunology |
title | Cytokine-armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56 dim CD16 dim natural killer cells |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T09%3A51%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cytokine-armed%20vaccinia%20virus%20promotes%20cytotoxicity%20toward%20pancreatic%20carcinoma%20cells%20via%20activation%20of%20human%20intermediary%20CD56%20dim%20CD16%20dim%20natural%20killer%20cells&rft.jtitle=International%20journal%20of%20cancer&rft.au=Wang,%20Ruonan&rft.date=2025-02-01&rft.volume=156&rft.issue=3&rft.spage=638&rft.pages=638-&rft.eissn=1097-0215&rft_id=info:doi/&rft_dat=%3Cpubmed%3E39400317%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/39400317&rfr_iscdi=true |